Tal Zaks - Bridging Science, Medicine, and Returns - [Invest Like the Best, EP.406]
Episode publishedPodcast: Invest Like the Best with Patr...Invest Like the Best with Patrick O'Shaughnessy
Transcript preview
Preview only
This year's presenting sponsor for invest like the best is Ramp. Ramp has built a command and control system for companies' finances. You can issue cards, manage approvals, make vendor payments of all kinds, and even automate closing your books all in one place. We did an incredibly deep dive on the company and its product as part of this new partnership, and what we heard and saw in customer surveys over and over again was that Ramp is the best product by far. We've been users ourselves since I started my business since long before I was able to spend so much time with the founders of Ramp an
are using our previous provider for over 30 years. We had the entire suite of products from portfolio accounting to trade order management, reporting, the reconciliation features. I didn't think that we would ever be able to switch to anything else. Andy, our head trader, suggested that I meet with Ridgeline. And they started off right away, not by introducing their company, but who they were hiring. And that caught my attention. They were pretty much putting in place a dream team of technical experts. Then they started talking about this single source of data. And I was like, what in the worl
Hello, and welcome, everyone. I'm Patrick O'Shaughnessy, and this is Invest Like the Best. This show is an open ended exploration of markets, ideas, stories, and strategies that will help you better invest both your time and your money. Invest like the best is part of the Colossus family of podcasts, and you can access all our podcasts, including edited transcripts, show notes, and other resources to keep learning at joincolossus.com. Patrick
O'Shaughnessy is the CEO of Positive Sum. All opinions expressed by Patrick and podcast guests are solely their own opinions and do not reflect the opinion of Positive Sum. This podcast is for informational purposes only and should not be relied upon as a basis for investment decisions. Clients of Positive Sum may maintain positions in the securities discussed in this podcast. To learn more, visit psum.vc.
My guest today is Tal Zaks. Tal is a physician scientist turned biotech executive and investor who served as Moderna's chief medical officer during their COVID 19 vaccine development, giving him an extraordinary perspective on one of modern medicine's pivotal moments. His combination of medical expertise, platform innovation experience, and investing acumen allows us to explore the interconnected challenges of turning scientific breakthroughs into viable medicines while generating venture scale returns. We dive deep into the lessons from Moderna's mRNA platform, examine how emerging technologi
in a nutshell, I'm a physician scientist who spent all my life figuring out how to translate the wonderful innovations of science in our era into better medicines for patients. I was fortunate to have been trained by some of the best. I trained for more years than I would recommend anybody in the sense of having done an MD, a PhD, a postdoc, a residency, a fellowship, 2 internships. I mean, you get the picture. And then I finally went out to do something in the world and spent the first part of my career in drug development, mostly as an oncologist and oncology drug development. And then the s
Well, at your intersection there of investing and deep science and personal hands on work and as a physician is exactly the Venn diagram that I've been searching for to have this kind of conversation, which is really about the current state and potential future states of medicine therapeutics and the investing returns that might be earned from
Keep exploring with a free account.
A free account preserves the short preview. Upgrade to Pro for the full transcript and episode chat.